FDA Investigator: Jessica S. Estriplet

- Jessica S. Estriplet first started conducting FDA inspections in 2021, with the last inspection in 2024. Over that time, Jessica S. Estriplet has conducted 23 inspections at 23 companies across 23 sites.

Get Jessica Estriplet's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Shanghai Ajinomoto Amino Acid Co., Ltd., Shanghai | 2024

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 SHANGHAI AUCTA PHARMACEUTICALS CO., LTD, Shanghai | 2024

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 Zhejiang Ausun Pharmaceutical Co., Ltd., Taizhou | 2024

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 Genzyme Corporation, Ridgefield | 2024

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 Dermaceutical Laboratories, LLC, Teterboro | 2024

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 Abich Inc, Montreal | 2023

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 Du-Var Laboratory, Boucherville | 2023

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 Dermolab Pharma Ltd., Sainte-Julie | 2023

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 International Trading Pharm Lab Inc, Paterson | 2023

Out-of-stock
Jessica S. Estriplet
Human Drugs Form 483

FDA 483 Elvi Pharma LLC, Piscataway | 2022

Out-of-stock
Jessica S. Estriplet
Human Drug Form 483